Zobrazeno 1 - 10
of 137
pro vyhledávání: '"Shu Dai"'
Autor:
Jing Wang, Xinyan Xue, Xingtao Zhao, Lin Luo, Juan Liu, Shu Dai, Fang Zhang, Rui Wu, Yanfang Liu, Cheng Peng, Yunxia Li
Publikováno v:
Journal of Advanced Research, Vol 60, Iss , Pp 183-200 (2024)
Introduction: Acute lung injury (ALI) is a lung disease characterized by inflammation and still requires further drug development. Forsythiaside A as the active compound of Forsythiae Fructus has the therapeutic potential for ALI. Objective: To inves
Externí odkaz:
https://doaj.org/article/9377d5549bd34fd090b25d337a7363c7
Autor:
Yu-xin Yao, Yu-jie Yu, Shu Dai, Chao-yang Zhang, Xin-yan Xue, Meng-ling Zhou, Chen-hao Yao, Yun-xia Li
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 175, Iss , Pp 116694- (2024)
The incidence of metabolic diseases has progressively increased, which has a negative impact on human health and life safety globally. Due to the good efficacy and limited side effects, there is growing interest in developing effective drugs to treat
Externí odkaz:
https://doaj.org/article/29ef159bb2d84b25a0bdf782a17dc889
Autor:
Jiliang Zhang, Shu Dai
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
BackgroundThere are many studies regarding the use of systemic immune-inflammation index (SII) to help predict oral squamous cell carcinoma (OSCC) prognosis, but findings have been inconsistent. The present meta-analysis was conducted to determine wh
Externí odkaz:
https://doaj.org/article/69e88524117043dbbd880d99eb60fb1b
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 167, Iss , Pp 115464- (2023)
Luteolin is a flavonoid widely present in various traditional Chinese medicines. In recent years, luteolin has received more attention due to its impressive liver protective effect, such as metabolic associated fatty liver disease, hepatic fibrosis a
Externí odkaz:
https://doaj.org/article/1b80e67fec454cc8a7758dd076cf5587
Autor:
Xingtao Zhao, Felix Kwame Amevor, Xinyan Xue, Cheng Wang, Zhifu Cui, Shu Dai, Cheng Peng, Yunxia Li
Publikováno v:
Journal of Nanobiotechnology, Vol 21, Iss 1, Pp 1-20 (2023)
Abstract Liver fibrosis could be the last hope for treating liver cancer and remodeling of the hepatic microenvironment has emerged as a strategy to promote the ablation of liver fibrosis. In recent years, especially with the rapid development of nan
Externí odkaz:
https://doaj.org/article/a60deaa0a02445dfb328df4b3526fb86
Autor:
Cheng Wang, Shu Dai, Xingtao Zhao, Yafang Zhang, Lihong Gong, Ke Fu, Cheng Ma, Cheng Peng, Yunxia Li
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 163, Iss , Pp 114882- (2023)
Celastrol is a pentacyclic triterpenoid extracted from the traditional Chinese medicine Tripterygium wilfordii Hook F., which has multiple pharmacological activities. In particular, modern pharmacological studies have demonstrated that celastrol exhi
Externí odkaz:
https://doaj.org/article/a0360ba3224f4debbb27eacf5b9a76c7
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 160, Iss , Pp 114297- (2023)
Rhubarb, in the form of a traditional Chinese medicine, is used in the treatment of chronic kidney disease (CKD). Previous studies have demonstrated that Rhubarb possesses a good nephroprotective effect, which primarily protects the kidneys from fibr
Externí odkaz:
https://doaj.org/article/7a318bef613d4056bec6fd3880c69c43
Autor:
Xingtao Zhao, Felix Kwame Amevor, Xinyan Xue, Cheng Wang, Zhifu Cui, Shu Dai, Cheng Peng, Yunxia Li
Publikováno v:
Journal of Nanobiotechnology, Vol 21, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/3eb211d6ee6d49108ac2ab54027a3131
Publikováno v:
Nutrients, Vol 15, Iss 9, p 2065 (2023)
Forsythia fruit, edible fruit of Forsythia suspensa (Thunb.) Vahl, which has been found to be effective in treating cholestasis. However, its key component for alleviating cholestasis has not been determined. In this study, four representative active
Externí odkaz:
https://doaj.org/article/ca4a9c3125894acf853ab31df3a6a9cf
Autor:
Xinyu Deng, Yubing Li, Xing Li, Zhenpeng Zhang, Shu Dai, Hefei Wu, Fangling Zhang, Qichao Hu, Yuan Chen, Jinhao Zeng, Xiao Ma
Publikováno v:
Molecules, Vol 27, Iss 23, p 8534 (2022)
Background: Drug-induced liver injury (DILI), represented by acetaminophen (APAP), is a common cause of acute liver failure in clinics. Paeoniflorin (PF) has been proven to demonstrate a significant hepatoprotective effect. However, it is still uncle
Externí odkaz:
https://doaj.org/article/c1d238df2aa64222a92622ef45fb6b66